Meng Qiu | Analysis Awards | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Meng Qiu | Analysis Awards | Best Researcher Award

Assoc Prof Dr. Meng Qiu, Ocean University of China, China

Associate Professor and Ph.D. Supervisor at the College of Chemistry and Chemical Engineering, Ocean University of China. His research focuses on nanobiomedicine and optoelectronics, including the preparation of low-dimensional nanomaterials and their biomedical applications. With over 80 publications and an H-index of 40, Dr. Qiu has received multiple awards, including the Shenzhen Natural Science Award and recognition as a top global scientist. He actively contributes as an editorial board member and guest editor for several journals.

Publication profile

Google Scholar

Education Background

Assoc. Prof. Dr. Meng Qiu holds a diverse educational background. He earned his Ph.D. in Physical Chemistry (2009-2013) from the State Key Laboratory of Molecular Reaction Dynamics, Institute of Chemistry, Chinese Academy of Sciences. He completed his M.S. in Applied Chemistry (2006-2009) at the Key Laboratory of Marine Chemistry Theory and Technology, Ocean University of China, following a B.S. in Applied Chemistry (2002-2006) at Qilu University of Technology. Dr. Qiu’s postdoctoral research includes positions at Shenzhen University (2016-2019) and the Qingdao Institute of Bioenergy and Bioprocess Technology (2014-2016) and served as a Research Professor at Korea University (2017-2018). 🌊🔬

 

Awards and Recognitions

Assoc. Prof. Dr. Meng Qiu has been honored with prestigious awards for his significant contributions to the field of nanobiomedicine. In 2023, he received the Second Prize of the Qingdao Natural Science Award for his groundbreaking work titled “Controllable Preparation and Photodynamic Therapy Mechanism of Two-Dimensional Pnictogens.” This research highlighted his innovative approach to preparing nanomaterials with potential therapeutic applications. Additionally, he was awarded the First Prize of the Shenzhen Natural Science Award in 2023 for his work on “Large-Scale Controllable Preparation of Two-Dimensional Phosphorene and Its Biomedical Applications.” This recognition underscores his excellence in developing novel nanomaterials that can significantly impact biomedical fields. Dr. Qiu’s achievements not only showcase his research expertise but also reflect his commitment to advancing science for societal benefit. 🌟🔬🏅

 

Research Interests

Assoc. Prof. Dr. Meng Qiu’s research focuses on the design, preparation, and functionalization of novel nanomaterials. He explores the optoelectronic properties of these materials and their interactions at the nanobiological interface, aiming to bridge the gap between nanotechnology and biology. His work also delves into the development of intelligent nanodiagnostic and therapeutic platforms and innovative biosensors, which have significant applications in medical diagnostics and treatment. Through his cutting-edge research, Dr. Qiu contributes to advancing the field of nanobiomedicine, enhancing our understanding of how nanomaterials can be utilized for health innovations. 🌍🧪

 

Publication Top Notes

  • “Novel concept of the smart NIR-light–controlled drug release of black phosphorus nanostructure for cancer therapy” – M Qiu et al. | Cited by: 755 | Year: 2018 📄✨
  • “Molecular dynamics and density functional theory study on relationship between structure of imidazoline derivatives and inhibition performance” – S Xia, M Qiu et al. | Cited by: 440 | Year: 2008 🔬🔍
  • “Omnipotent phosphorene: a next-generation, two-dimensional nanoplatform for multidisciplinary biomedical applications” – M Qiu et al. | Cited by: 403 | Year: 2018 🧬🌐
  • “Biocompatible and biodegradable inorganic nanostructures for nanomedicine: silicon and black phosphorus” – M Qiu et al. | Cited by: 266 | Year: 2019 💊🌱
  • “Conceptually novel black phosphorus/cellulose hydrogels as promising photothermal agents for effective cancer therapy” – C Xing, S Chen, M Qiu et al. | Cited by: 259 | Year: 2018 🧪🔥
  • “Electrochemical behavior of Q235 steel in saltwater saturated with carbon dioxide based on new imidazoline derivative inhibitor” – FG Liu, M Du, M Qiu | Cited by: 258 | Year: 2009 ⚙️🌊
  • “The rise of 2D photothermal materials beyond graphene for clean water production” – Z Xie, Y Duo, M Qiu et al. | Cited by: 243 | Year: 2020 💧📈
  • “Current progress in black phosphorus materials and their applications in electrochemical energy storage” – M Qiu et al. | Cited by: 239 | Year: 2017 🔋🔋
  • “Graphene oxide/black phosphorus nanoflake aerogels with robust thermo-stability and significantly enhanced photothermal properties in air” – C Xing, M Qiu et al. | Cited by: 225 | Year: 2017 ☀️🌡️
  • “Black phosphorus-based photothermal therapy with aCD47-mediated immune checkpoint blockade for enhanced cancer immunotherapy” – Z Xie, M Qiu et al. | Cited by: 177 | Year: 2020 🦠🛡️

Conclusion

Dr. Meng Qiu’s extensive publication record, significant impact in his field, recognition through awards, and leadership roles in academic circles make him a highly suitable candidate for the Research for Best Researcher Award. His innovative research and contributions to nanobiomedicine and optoelectronics position him as a leader in his field, deserving of this recognition.

 

 

Assist Prof Dr. Naglaa Ashmawy | Analytical Techniques Award | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Naglaa Ashmawy | Analytical Techniques Award | Best Researcher Award 

Assist Prof Dr. Naglaa Ashmawy , Gulf Medical University , United Arab Emirates

Dr. Naglaa Saad Eldin Mostafa Ashmawy is a distinguished Assistant Professor in the Pharmaceutical Sciences Department at Gulf Medical University, Ajman, UAE. With a Ph.D. in Pharmaceutical Sciences from Ain Shams University, Cairo, Egypt (2019), her research focuses on the phytochemical and biological studies of plants in the Araliaceae family. She earned her M.Sc. in Natural Products Chemistry from the same institution in 2013, with research on the genus Erythrina of the Leguminosae family.Dr. Ashmawy’s career spans both academia and industry. She currently coordinates the International Foundation Programs at Gulf Medical University and has held roles as a visiting assistant professor at Rochester Institute of Technology, Dubai, and City University College of Ajman. Her previous experience includes a post-doctoral fellowship at Sharjah Institute for Medical Research, and she served as an Assistant Professor at Ain Shams University, where she was also involved in accreditation committees.

 

Profile :

Scopus

Google Scholar

Orcid

Education

🎓 Ph.D. in Pharmaceutical Sciences, Natural Products Chemistry, Ain Shams University, Cairo (2019)
🎓 M.Sc. in Pharmaceutical Sciences, Natural Products Chemistry, Ain Shams University (2013)
🎓 B.Sc. in Pharmaceutical Sciences, Ain Shams University (2007)

Work Experience

🧑‍🏫 Assistant Professor, Gulf Medical University (Oct. 2023–Present)
🧑‍🏫 Visiting Assistant Professor, Rochester Institute of Technology-Dubai (Aug. 2021–Jun. 2023)
🧑‍🏫 Part-time Assistant Professor, Gulf Medical University (Sep. 2022–Aug. 2023)
🧑‍🏫 Visiting Assistant Professor, City University College of Ajman (Sep. 2020–Jun. 2021)
🔬 Postdoctoral Fellow, Sharjah Institute for Medical Research (Sep. 2019–Aug. 2023)
🧑‍🏫 Assistant Professor of Pharmacognosy, Ain Shams University (Dec. 2018–Aug. 2019)
🧑‍🏫 Lecturer, Ain Shams University (June 2013–Dec. 2018)
🧪 Lab Instructor, Ain Shams University (May 2008–June 2013)
💊 Pharmacist, Nilly Pharmacy, Cairo (Jan. 2008–Apr. 2008)

Teaching Experience

🔬 General and Organic Chemistry, Pharmaceutical Analysis, Biochemistry, Complementary Medicine
🧪 Organic Chemistry, Introduction to Chemical Analysis, Analytical Chemistry
🌿 Pharmacognosy, Quality Control of Herbal Products, Phytochemistry

Administrative Experience

📋 Coordinator, International Foundation Programs, Gulf Medical University
📋 Chair, College of Pharmacy Quality Assurance Committee, Gulf Medical University
📋 Committee Member for NAQAAE Accreditation, Ain Shams University

Research Skills

🔍 Microscopy, Sample Preparation, Dyeing, Imaging
🔬 HPLC, HPTLC, LC/MS
🌿 Essential Oil Extraction, GC, GC/MS
📊 Metabolomic Research, NMR, LC/MS, GC/MS
🔍 Structure Elucidation of Secondary Metabolites
💻 Software: MS Office, Mestrenova, Xcalibar, EndNote, AMDIS, Chenomx, metaboAnalyst

 

Publication Top Notes :

Flavonoids are promising safe therapy against COVID-19

Citation -151

A New Xanthone Glycoside from Mangifera indica L.: Physicochemical Properties and In Vitro Anti-Skin Aging Activities

Citation -30

A comprehensive review of the health benefits of flaxseed oil in relation to its chemical composition and comparison with other omega-3-rich oils

Citation -28

The genus Polyscias (Araliaceae): A phytochemical and biological review

Citation -25

Marine sponge is a promising natural source of anti-SARS-CoV-2 scaffold

Citation -22

Dr. Naveen Dubey | Analytical Award | Best Researcher Award

Posted on by ScienceFather

Dr. Naveen Dubey | Analytical Award | Best Researcher Award 

Dr. Naveen Dubey , Mediclin Clinical Services , India

Naveen Kumar Dubey is a distinguished pharmaceutical expert with over 22 years of experience in analytical development and bioanalytical research. Currently serving as the Vice President of CRO Operations at Mediclin Clinical Services Pvt. Ltd., Naveen oversees bioanalytical CROs and ensures adherence to GLP and GCP standards. His role involves managing operational budgets, implementing strategic plans, and coordinating with various stakeholders.

Profile :

Google Scholar

Education:

  • Ph.D. in Chemistry
    IGNOU, Delhi, India (2017-2020) 📚
  • M.Tech. in Modern Methods of Chemical Analysis
    IIT Delhi, India (Jul 1999 – Dec 2000) 🎓
  • M.Sc. in Organic Chemistry
    Delhi University, India (1997-1999) 🧪

Work Experience:

  • Vice President-CRO Operation
    Mediclin Clinical Services Pvt. Ltd., Lucknow, India (Jan 2023 – Present)
    🚀 Oversaw bioanalytical CROs, managed operational budget (~700,000 USD), and coordinated study deliverables.
  • Associate Director (HOD) – Bioanalytical Operation
    Jubilant Generics Ltd., Noida, India (Jun 2020 – Jan 2023)
    🧬 Managed bioanalytical operations, led a team, ensured GCLP & GDP compliance, and handled regulatory inspections.
  • Research Scientist – Clinical Pharmacology and Pharmacokinetics
    Ranbaxy Research Laboratories, Gurgaon, Haryana, India (Oct 2002 – Jan 2006)
    🔬 Conducted bioequivalence studies, developed and validated methods for drug estimation, and ensured compliance with USFDA norms.
  • Research Officer – Analytical Division
    Sun Pharma Advanced Research Centre, Akota, Baroda, Gujarat, India (Feb 2001 – Oct 2002)
    🧪 Started professional career in pharmaceutical R&D, handled various drug analyses, and managed calibration of HPLC instruments.

 

Publication top Notes :

Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC–MS/MS and its application in bioequivalence studies

Citation – 29

Bioanalytical method development and validation of alimemazine in human plasma by LC-MS/MS and its application in bioequivalence studies

Citation – 10

Interconversion from N‐Desmethyl Clomipramine to Clomipramine and its impact on a bioequivalence study

Citation – 7

Ultra-performance liquid chromatography electrospray ionization–tandem mass spectrometry method for the simultaneous determination of itraconazole and hydroxy itraconazole in …

Citation – 7

A liquid chromatography tandem mass spectrometry based regulatory compliant method for the determination of tenofovir in human serum

Citation – 4